IL22 in Egyptian SLE patients, could it reflect disease activity, skin or renal involvement or is it only an expensive ESR?

Pan, 2008, Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus, Nat Clin Pract Rheumatol, 4, 352, 10.1038/ncprheum0815 Mosmann, 1989, TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties, Annu Rev Immunol, 7, 145, 10.1146/annurev.iy.07.040189.001045 Dolhain, 1996, Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis, Arthritis Rheum, 39, 1961, 10.1002/art.1780391204 Wedderburn, 2000, Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis, Arthritis Rheum, 43, 765, 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B Weaver, 2006, Th17: an effector CD4 T cell lineage with regulatory T cell ties, Immunity, 24, 677, 10.1016/j.immuni.2006.06.002 Duhen, 2009, Production of interleukin 22 but not interleukin17 by a subset of human skin-homing memory T cells, Nat Immunol, 10, 857, 10.1038/ni.1767 Eyerich, 2009, Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling, J Clin Invest, 119, 3573 Trifari, 2009, Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells, Nat Immunol, 10, 864, 10.1038/ni.1770 Dumoutier, 2000, Cloning and characterization of IL-10-related Tcell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9, J Immunol, 164, 1814, 10.4049/jimmunol.164.4.1814 Zhang, 2011, Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention, Mol Cell Biochem, 353, 41, 10.1007/s11010-011-0772-y Yang, 2013, Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus, J Clin Immunol, 33, 767, 10.1007/s10875-013-9878-1 Pan, 2013, Emerging role of interleukin-22 in autoimmune diseases, Cytokine Growth Factor Rev, 24, 51, 10.1016/j.cytogfr.2012.07.002 Dumoutier, 2000, Cloning and characterization of IL-10-related T-cell derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9, J Immunol, 164, 1814, 10.4049/jimmunol.164.4.1814 Tagoe, 2012, JAK2 inhibition in murine systemic lupus erythematosus, Immunotherapy, 4, 369, 10.2217/imt.12.20 Jia, 2011, Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK–STAT and NF-kappaB signaling pathways, PLoS One, 6, e27006, 10.1371/journal.pone.0027006 Jiang, 2009, MOG(35–55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways, Eur J Immunol, 39, 789, 10.1002/eji.200838427 Arumugam, 2012, Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant, Exp Mol Pathol, 93, 183, 10.1016/j.yexmp.2012.04.012 Noubade, 2011, Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis, Blood, 118, 3290, 10.1182/blood-2011-02-336552 Pan, 2009, Decreased serum IL-22 levels in patients with systemic lupus erythematosus, Clin Chim Acta, 401, 179, 10.1016/j.cca.2008.11.009 Cheng, 2009, Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus, Ann Rheum Dis, 68, 604, 10.1136/ard.2008.097089 da Rocha, 2012, Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity, J Rheumatol, 39, 1320, 10.3899/jrheum.111027 Semerano, 2012, Anti-cytokine vaccination: a new biotherapy of autoimmunity?, Autoimmun Rev, 11, 785, 10.1016/j.autrev.2012.02.003 Ke, 2011, IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis, J Immunol, 187, 2130, 10.4049/jimmunol.1100482 Zenewicz, 2008, IL-22 inflammation: leukin’ through a glass onion, Eur J Immunol, 38, 3265, 10.1002/eji.200838655 Kagami, 2010, Circulating Th17, Th22, and Th1 cells are increased in psoriasis, J Invest Dermatol, 130, 1373, 10.1038/jid.2009.399 Truchetet, 2011, Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease, Arthritis Res Ther, 13, R166, 10.1186/ar3486 Shen, 2009, Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis, Arthritis Rheum, 60, 1647, 10.1002/art.24568 Zhang, 2011, Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis, J Clin Immunol, 31, 606, 10.1007/s10875-011-9540-8 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Gladman, 2002, Systemic lupus erythematosus disease activity index 2000, J Rheumatol, 29, 288 Pan, 2008, Anti-neutrophil cytoplasmic anti- bodies in new-onset systemic lupus erythematosus and lupus nephritis, Inflammation, 31, 260, 10.1007/s10753-008-9073-3 Cope, 2004, Emerging approaches for the therapy of autoimmune and chronic inflammatory disease, Curr Opin Immunol, 16, 780, 10.1016/j.coi.2004.09.005 Chatenoud, 2006, Immune therapies of autoimmune diseases: are we approaching a real cure?, Curr Opin Immunol, 18, 710, 10.1016/j.coi.2006.09.004 Zhao, 2013, IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus, Exp Biol Med (Maywood), 238, 193, 10.1177/1535370213477597 Duhen, 2009, Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells, Nat Immunol, 10, 857, 10.1038/ni.1767 Kagami, 2010, Circulating Th17, Th22, and Th1 cells are increased in psoriasis, J Invest Dermatol, 130, 1373, 10.1038/jid.2009.399 Zhang, 2011, Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis, J Clin Immunol, 31, 606, 10.1007/s10875-011-9540-8 Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007 Wolk, 2010, Biology of interleukin-22, Semin Immunopathol, 32, 17, 10.1007/s00281-009-0188-x Zenewicz, 2008, Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease, Immunity, 29, 947, 10.1016/j.immuni.2008.11.003 Zheng, 2007, Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis, Nature, 445, 648, 10.1038/nature05505 Ma, 2008, IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation, J Clin Invest, 118, 597 Wolk, 2009, IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not, J Mol Med (Berl), 87, 523, 10.1007/s00109-009-0457-0 Kolb, 1992, Nitric oxide: a pathogenetic factor in autoimmunity, Immunol Today, 13, 157, 10.1016/0167-5699(92)90118-Q Jonuleit, 1996, Cytokines and their effects on maturation, differentiation and migration of dendritic cells, Arch Dermatol Res, 289, 1, 10.1007/s004030050144 Fairhurst, 2008, Systemic TNF-α drives kidney nephritis in B6.Sle123 mice, Eur J Immunol, 38, 1948, 10.1002/eji.200837925 Jacob, 1990, Heritable major histo-compatibility complex class II-associated difference in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus, Proc Natl Acad Sci USA, 87, 1233, 10.1073/pnas.87.3.1233 Ma, 2010, The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients, Clin Rheumatol, 29, 1251, 10.1007/s10067-010-1510-7 Henriques, 2010, Frequency and functional activity of Th17, Tcl7 and other T-cell subsets in systemic lupus erythematosus, Cell Immunol, 264, 97, 10.1016/j.cellimm.2010.05.004